Immunic, Inc.
USD15.41
+0.11 (+0.72%)
CEO
Daniel Vitt
IPO Date
2014-04-17
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$15.20
Prev. Close
$15.30
Day Low
$15.20
Day High
$15.78
52W Low
$5.06
52W High
$15.84
Market Cap
$0.15B
Volume
0.36M
| -1.0 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -323.6% | -172.4% | 0.05 | 2.12 | -0.7 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -105.9% | -94.2% | 0.01 | 9.62 | -0.4 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -73.1% | -66.8% | 0.01 | 9.21 | -2.4 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -27.7% | -26.2% | 0.01 | 15.93 | -5.4 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -59.7% | -52.8% | 0.01 | 4.56 | -2.2 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -333.7% | -276.9% | 2.99 | 5.67 | -0.2 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -104.1% | -86.2% | 0.00 | 5.65 | -4.6 |
| 31 Dec 2016 | FY | -28529.7% | -648744.6% | -70.1% | -64.0% | 0.00 | 11.22 | -3.3 |
| -1.1 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -243.6% | -62.8% | 0.01 | 1.31 | -1.7 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -79.1% | -43.7% | 0.03 | 2.19 | -0.9 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | 481.8% | -124.2% | -0.18 | 0.74 | -1.1 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -136.6% | -61.6% | 0.05 | 1.77 | -0.9 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -59.1% | -37.6% | 0.02 | 2.71 | -1.7 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -33.6% | -24.7% | 0.02 | 3.75 | -1.3 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -35.4% | -28.4% | 0.01 | 5.09 | -1.1 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -74.6% | -39.7% | 0.05 | 2.12 | -0.8 |